Tag: CBT > CBD DEA

Cannabis Rescheduling

Trump Promotes Hemp-Derived CBD For Senior Health Care in Shared Video

The president shared a video advocating for Medicare coverage for CBD and to fully integrate cannabis into the health care system for those 65 and older.

September 29, 2025

Cannabis Rescheduling

DEA Responds to ‘Out of Time’ Cannabis Rescheduling Claims

In response to cannabis advocates’ renewed motion to disqualify the DEA from the hearing process, the DEA says there is no new evidence to reconsider.

January 13, 2025

Cannabis Industry Research

Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling

The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.

September 20, 2024

Texas

Allen Police Department, DEA Raid 9 Texas Vape Shops, Destroy Hemp Products

Local authorities accused the shops of selling noncompliant products, sometimes to minors. An attorney said the police and DEA ‘overstepped their authority.’

August 28, 2024

Hemp Regulations in U.S.

DEA May Propose Regulations That Would Threaten the Hemp-Derived Cannabinoid Industry and Cast a Dark Cloud Over CBD Industry

The federal agency announced in early May that it plans to soon propose new rules that would classify synthetically derived cannabinoids as controlled substances and would decontrol CBD up to 0.1% THC on a weight-to-weight or weight-to-volume basis.

May 26, 2023

CBD Industry

Hemp Numbers Plummet Across the Board in 2022 USDA Acreage and Production Survey

The value of industrial hemp totaled $238 million in 2022, down 71% from $824 million in 2021.

April 28, 2023

CBD Industry

US Lawmakers Reintroduce Bipartisan Bills to Regulate CBD

The reintroduction of the measures comes after the FDA called on Congress to regulate CBD in dietary supplements, conventional foods and animal products.

March 17, 2023

Legislation and Regulation

UPDATED: President Biden Signs Bipartisan Cannabis Research Bill

The legislation cleared its final congressional hurdle with a voice vote last month in the Senate, paving way for researchers to fully study the impacts of cannabis use.

December 2, 2022

Legislation and Regulation

FDA’s Most Recent Hire Could Lead to CBD Regulation

The federal agency named Norman Birenbaum as senior public health advisor at the agency’s Center for Regulatory Programs Sept. 26.

September 28, 2022

Hemp Research

What’s Up With Pet CBD?

As consumer interest in cannabinoids for pets increases, so do questions about capitalizing on the growing market.

May 11, 2022

Compliance

Selling Hemp-Derived Delta-9 THC Products? Here's What to Consider

Marshall Custer of Husch Blackwell law firm dives into legal considerations for hemp businesses selling these products.

May 10, 2022

Interviews & Opinion

FDA Issues First Batch of Warning Letters to Delta-8 THC Product Manufacturers

The federal agency is warning five companies that they are marketing unapproved new drugs, misbranding their wares and unlawfully adding delta-8 THC to food products.

May 6, 2022